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letters to the editor 
5-YEAR SURVIVAL OF A PATIENT 
WITH MALIGNANT THYMOMA 
WITH SUPERIOR VENA CAVAL 
SYNDROME 
Dear Sir, 
Thymoma is an uncommon neoplasm that is derived from the 
epithelial cells of the thymus. It is well known for its 
association with myasthenia gravis (MG) or other 
autoimmune disease, histologic variability, and heterogeneity 
of malignant behaviour.! Surgery remains the mainstay of 
treatment while radiation and chemotherapy also have been 
applied widely as adjuvant and paliiative procedures. Most 
malignant thymomas are slow-growing tumors which 
uncommonly metastasize hematogenously and have a 
tendency to recur locally. 
A 41-year-old man presented to the Emergency Room with a 
4-month history of cough, shortness of breath and low grade 
intermittent fever with no other past or present medical 
problems. On physical examination, he had extensive facial 
swelling and engorged neck veins. The rest of the physical 
examination was unremarkable. Chest X-ray showed 
Widening of mediastinum. CT-scan of the chest was 
performed which showed a lobulated soft tissue mass (6x4cm) 
in the anterior mediastinum along with calcification in its 
peripheral margins. Superior Vena Caval (SVC) thrombosis 
Was also identified with collateral development. VATS (video 
assisted thoracoscopic surgery) was performed to get the 
biopsy and the histopathology report showed changes 
consistent with malignant thymoma. Elective thymectomy 
Was performed. The anterior mediastinal mass was found to 
he hard and encasing the SVC which was thrombosed. Further 
dissection revealed that the innominate artery;. right carotid 
and right subclavian arteries were encased in the thymoma. 
'fhe tumor was projecting deep posterior to the pulmonary 
artery and around the aorta and had completely invaded the 
left phrenic nerve and left innominate vein. Pulmonary 
extension of the tumor was evident by involvement of the 
right and left upper lubes. The entire tumor along with 
portions of both upper lobes was removed. Since there was 
lrtvolvement of the left phrenic nerve as well, pericardium and 
the left phrenic nerve were taken along with the tumor. The 
tumor was shaved off the thrombosed SVC. 
The patient received postoperative radiotherapy and has been 
followed by the oncology service routinely since surgery. The 
facial swelling subsided completely 3 months after surgery. 
On a 5 years follow-up, the patient has shown no recurrence of 
his tumor on CAT scan and is total! y asymptomatic. 
alignant thymomas are rare, slow-growing tumors and 
tients commonly present with cough, chest pain, phrenic 
nerve palsy or SVC syndrome, or less frequently with fever, r~ght sweats and weight loss. CT scanning is usually accurate 
In predicting tumor size, location and invasion into vessels, 
'pericardium and lung. 
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Even though invasiveness of the tumor remains the single 
most consistent factor in predicting outcome, several factors 
adversely affect the prognosis of malignant thymoma as well 
including' intrathoracic or extrathoracic metastasis, tumor 
size > lOcm, extent of surgical re..c;;ection, tracheal or vascular 
compromise, age < 30 years and epithelial/ mixed histologies. 
Initially, the presence of an associated paraneoplastic 
syndrome or myasthenia gravis was regarded as a negative 
prognostic factor,2,.3A however, now these are not associated 
with inferior outcome any more, possibly because of earlier 
detection.2 
Surgical resection remains the main mode of therapy, with an 
enbloc removal for invasive tumors in patients who can 
tolerate surgery and do not have extensive metastatic disease. 
The extent and completeness of surgical resection determines 
outcume.4 In patients with extensive metastasis and unstable 
medical condition, debulking or biopsy may be the only 
option. In such cases, postoperative radiotherapy has been 
shown to increase survival rates.2 
Thymomas appropriately treated by complete surgical 
resection, result in a 960% 10-year surviva.l The stage of the 
disease has an important impact upon survival outcomes. 
Malignant thymoma often involves the phrenic nerves and 
there is a probabililty of impaired respiratory function if the 
nerve is divided. Preoperative pulmonary function tests 
should be performed in all patients so that any respiratory 
compromise following surgical resection of the phrenic nerve 
can be estimated. In patients with completely resected stage II 
or III thymomas, adjuvant radiotherapy reduces the rate of 
local recurrence from approximately 28 to 5%.4 
Thymomas are chemosensitive malignancies.s It is 
recommended that patients with unresectable disease should 
be given aggressive management with trimodality therapy. 
Cisplatin-containing regimens are by far the most active with 
overall response rates of 70-80%, of which half are complete. 
The most commonly used regimens are ADOC:, PAC and Ep 
(etoposide and cisplatin). For recurrent disease, ADOC or PAC 
regimen can be used and in cases of patients not being able to 
tolerate cisplatin, carbuplatin can be substituted. Currently, 
carboplatin and paclitaxel combination is being shtdied in 
clinical research. 
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ERRATA 
1. The name of co-author, Ali S.M. Akhtar has been misprinted as 
S.M. Akhtar in the article "NEONATAL COMPLICATIONS IN 
INFANTS BORN TO DIABETIC MOTHERS" published in 
JCPSP 2006, Vol. 16 (3): 212-15. The name may be corrected and 
read as A.S.M. Akhtar. 
2. A discrepancy has occurred in the authorship of the article: 
"TRACHEAL INJURY DUE TQ BLUNT CHEST TRAUMA: 
A RARE SURGICAL EMERGENCY" by Usman Ahmad, 
Muhammad A. Javed and Saulat H. Fatimi, published in 
JCPSP 2006,Vol. 16 (6): 422-23. The name of fourth co-author, 
Fahad Shuja, was inadvertently omitted and could not be printed. 
His name may be included in the above article and the authors' 
list should read as: Usman Ahmad, Muhammad A. Javed, Saulat 
H. Fatimi and Fahad Shuja. 
3. Due to a typographic error the 'u' of edu was omitted from the 
E-mail address of correspondence author of the article titled 
"CORD BLOOD LEPTIN LEVELS IN PAKISTANI NEWBORNS: 
RELATIONSHIP WITH BIRTH WEIGHT, LENGTH AND 
OCCIPITOFRONTAL CIRCUMFERENCE" published in JCPSP 
2006, Vol. 16 (6): 393-95. The E-mail address should read as 
ghulam.lakho@aku.edu. 
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